Exacerbation of schizophrenia by varenicline

被引：115

作者：

Freedman, Robert

机构：

来源：

AMERICAN JOURNAL OF PSYCHIATRY | 2007年 / 164卷 / 08期

关键词：

D O I：

10.1176/appi.ajp.2007.07020326

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：1269 / 1269

页数：1

共 3 条

[1] Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation -: A randomized controlled trial [J].

Gonzales, David ;

Rennard, Stephen I. ;

Nides, Mitchell ;

Oncken, Cheryl ;

Azoulay, Salomon ;

Billing, Clare B. ;

Watsky, Eric J. ;

Gong, Jason ;

Williams, Kathryn E. ;

Reeves, Karen R. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (01) :47-55

[2] Proof-of-concept trial of an α7 nicotinic agonist in schizophrenia [J].

Olincy, Ann ;

Harris, Josette G. ;

Johnson, Lynn L. ;

Pender, Vicki ;

Kongs, Susan ;

Allensworth, Diana ;

Ellis, Jamey ;

Zerbe, Gary O. ;

Leonard, Sherry ;

Stevens, Karen E. ;

Stevens, James O. ;

Martin, Laura ;

Adler, Lawrence E. ;

Soti, Ferenc ;

Kem, William R. ;

Freedman, Robert .

ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (06) :630-638

[3] Successful tobacco dependence treatment in schizophrenia [J].

Williams, Jill M. ;

Foulds, Jonathan .

AMERICAN JOURNAL OF PSYCHIATRY, 2007, 164 (02) :222-227

← 1 →